Major Bayer shareholder Harris backs CEO’s focus on internal restructuring  | Reuters News Agency


Business & FinanceHealth

Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO. 

Market Impact

The news caused Bayer’s shares to significantly narrow losses. The group’s stock closed down 0.9% following the comments after having fallen as much as 6.3% earlier in the session.

Article Tags

Topics of Interest: Business & FinanceHealth

Type: Reuters Best

Sectors: Business & FinancePharmaceuticals & Healthcare

Regions: Europe

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Important Regional Story


Source link